International Ophthalmology Companies Positioned in Gene Therapy As the policies of Europe and the United States in recent years have encouraged the development of rare disease drugs, which are entitled to a tax deduction for trial expenses and an exclusivity period of 7-10 years, coupled with the fact that the rare disease drug ... Read more